Mojca Tuta
YOU?
Author Swipe
View article: Total neoadjuvant therapy <i>vs</i> standard therapy of locally advanced rectal cancer with high-risk factors for failure
Total neoadjuvant therapy <i>vs</i> standard therapy of locally advanced rectal cancer with high-risk factors for failure Open
Compared to standard therapy, TNT provides better outcome for LARC patients with high-risk factors for failure, in terms of pCR and neoadjuvant rectal score.
View article: Influence of concurrent capecitabine based chemoradiotherapy with bevacizumab on the survival rate, late toxicity and health-related quality of life in locally advanced rectal cancer: a prospective phase II CRAB trial
Influence of concurrent capecitabine based chemoradiotherapy with bevacizumab on the survival rate, late toxicity and health-related quality of life in locally advanced rectal cancer: a prospective phase II CRAB trial Open
Background Few studies reported early results on efficacy, toxicity of combined modality treatment for locally advanced rectal cancer (LARC) by adding bevacizumab to preoperative chemoradiotherapy, but long-term data on survival, and late …
View article: Total neoadjuvant treatment of locally advanced rectal cancer with high risk factors in Slovenia
Total neoadjuvant treatment of locally advanced rectal cancer with high risk factors in Slovenia Open
Background In the light of a high rate of distant recurrence and poor compliance of adjuvant chemotherapy in high risk rectal cancer patients the total neoadjuvant treatment was logical approach to gaining acceptance. We aimed to evaluate …